5-Aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors

Urologia Internationalis

Volumn 63, Issue 1, 1999, Pages 27-31

  Kriegmair, Martin ^a   Zaak, Dirk ^a   Knuechel, Ruth ^a   Baumgartner, Reinhold ^a   Hofstetter, Alfons ^a  

^a NONE

Author keywords

5 Aminolevulinic acid; Bladder cancer; Photosensitizer; Preneoplasia; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; TUMOR MARKER;

ARTICLE; BIOPSY; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ENDOSCOPY; FLUOROSCOPY; GERMANY; HISTOLOGY; HUMAN; KRYPTON LASER; LIGHT; PRIORITY JOURNAL; REGIONAL PERFUSION; TUMOR RECURRENCE; URINARY TRACT CANCER;

EID: 0032725097     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030415     Document Type: Article

References (27)

1. Kennedy JC, Pottier RH: Endogenous protoporphyrin IX a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol [B] 1992;14:275-292.
2. Kriegmair M, Baumgartner R, Hofstetter AG: Intravesikale Instillation von Delta-Aminolävulinsäure (ALA) - Eine neue Methode zur photodynamischen Diagnostik und Therapie. Laser Med 1992;8:83.
3. Peng O, Warloe T, Berg K, Moan J, Kongshaug M, Giereksky KE, Nesland JM: 5-Aminolevulinic acid-based photodynamic therapy: Clinical research and future challenges. Cancer 1997;79:2282-2308.
4. Klän R, Loy V, Huland H: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 1991;146: 316-318.
5. Köhrmann KU, Woeste M, Kappes J, Rassweiler J, Alken P: Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 1994;25:208.
6. Vögeli TA, Grimm MO, Ackermann R: Prospective study for quality control of TUR of bladder tumors by routine 2nd TUR (ReTUR). J Urol 1998;159(suppl):143.
7. Mersdorf A, Brauers A, Wolf JM, Schneider V, Jakse G: 2nd TUR for superficial bladder cancer: A must. J Urol 1998;159(suppl):143.
8. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD: Superficial bladder tumors (stage pTa grades 1 and 2): The importance of recurrence pattern following initial resection. J Urol 1986;135:920-922.
9. Pryor JP: Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. Br J Urol 1973;45:586-592.
10. Brausi M, Kurth K-H, VanderMeyden AP, Sylvester RJ: Variability in the three-months recurrence rate after TUR in superficial cell carcinoma (TCC) of the bladder: A combined analysis of 8 EORTC studies. J Urol 1998; 159(suppl):143.
11. Smith G, Elton RA, Beynon LL, Newsam JE, Chisholm GD, Hargreave TB: Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Br J Urol 1983;55:665-669.
12. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR: Superficial bladder cancer: Progression and recurrence. J Urol 1983;130:1083-1086.
13. Flamm J, Dona S: The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma. Eur Urol 1989;2: 81-85.
14. Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM: Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993;150:60-64.
15. Kiemeney LA, Witjes JA, Heijbroek RP, Koper NP, Verbeek AL, Debruyne FM: Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. Br J Urol 1994;73:164-171.
16. Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 1995;154:379-383.
17. Vicente J, Chechile G, Algaba F: Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder. Eur Urol 1987;13:15-16.
18. Kriegmair M, Baumgartner R, Knuechel R, Steinbach P, Ehsan A, Lumper W, Hofstadter F, Hofstetter A: Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminovulinic acid. Urology 1994;44:836-841.
19. Kriegmair M, Stepp H, Steinbach P, Lumper W, Ehsan A, Stepp HG, Rick K, Baumgartner R, Hofstetter A: Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: A new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. Urol Int 1995;55:190-196.
20. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996;155:105-109.
21. Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R: Pharmacokinetics of 5-aminolevulinic acid induced protoporphyrin IX in skin and blood. J Photochem Photobiol [B] 1997;40:313-319.
22. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagnieres G, Zimmer G, Guillou L, Schmidlin F, Graber P, van den Bergh H, Leisinger HJ: Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 1997;20:402-408.
23. Filbeck T, Rössler W, Straub M, Kiel HJ, Knüchel R, Wieland WF: Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolaevulinic acid. Endourology 1998; 13:117-121.
24. König F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF: Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU In: 1999;83:129-135.
25. Kriegmair M, Zaak D, Stepp H, Stepp H, Baumgartner R, Knuechel R, Hofstetter A: Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid induced fluorescence endoscopy. Eur Urol 1999;36:386-392.
26. Kriegmair M, Mitglieder der AFE-Studiengruppe: Die transurethrale Elektroresektion von Harnblasentumoren mit und ohne 5-Aminolävulinsäure induzierter Fluoreszenz-Endoskopie. Urologe [A] 1998;37:S15.
27. Bouffioux Ch, Kurth KH, Bono A, Oosterlinck W, Boeken Kruger C, De Pauw M, Sylvester R: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European organisation for research and treatment of cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol 1995;153:934-941.